BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 21985458)

  • 1. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
    Du JZ; Du XJ; Mao CQ; Wang J
    J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable ZnO@polymer core-shell nanocarriers: pH-triggered release of doxorubicin in vitro.
    Zhang ZY; Xu YD; Ma YY; Qiu LL; Wang Y; Kong JL; Xiong HM
    Angew Chem Int Ed Engl; 2013 Apr; 52(15):4127-31. PubMed ID: 23463695
    [No Abstract]   [Full Text] [Related]  

  • 3. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
    Lale SV; R G A; Aravind A; Kumar DS; Koul V
    Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W; Zhou J; Mann A; Wang Y; Zhu L
    Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacious anticancer drug delivery mediated by a pH-sensitive self-assembly of a conserved tripeptide derived from tyrosine kinase NGF receptor.
    Moitra P; Kumar K; Kondaiah P; Bhattacharya S
    Angew Chem Int Ed Engl; 2014 Jan; 53(4):1113-7. PubMed ID: 24338837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery.
    Wang G; Maciel D; Wu Y; Rodrigues J; Shi X; Yuan Y; Liu C; Tomás H; Li Y
    ACS Appl Mater Interfaces; 2014 Oct; 6(19):16687-95. PubMed ID: 25167168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
    Guo M; Que C; Wang C; Liu X; Yan H; Liu K
    Biomaterials; 2011 Jan; 32(1):185-94. PubMed ID: 21067808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
    Villa R; Cerroni B; Viganò L; Margheritelli S; Abolafio G; Oddo L; Paradossi G; Zaffaroni N
    Colloids Surf B Biointerfaces; 2013 Oct; 110():434-42. PubMed ID: 23759384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
    Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
    ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-sensitive disassembly of amphiphilic copolymer based micelles.
    Ryu JH; Roy R; Ventura J; Thayumanavan S
    Langmuir; 2010 May; 26(10):7086-92. PubMed ID: 20073533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
    Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
    Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agents.
    Miao Q; Xu D; Wang Z; Xu L; Wang T; Wu Y; Lovejoy DB; Kalinowski DS; Richardson DR; Nie G; Zhao Y
    Biomaterials; 2010 Oct; 31(28):7364-75. PubMed ID: 20599267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
    Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
    J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermo- and pH dual responsive polymeric micelles and nanoparticles.
    Kalhapure RS; Renukuntla J
    Chem Biol Interact; 2018 Nov; 295():20-37. PubMed ID: 30036501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux.
    Chavanpatil MD; Khdair A; Gerard B; Bachmeier C; Miller DW; Shekhar MP; Panyam J
    Mol Pharm; 2007; 4(5):730-8. PubMed ID: 17705442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminescent carbon dot-gated nanovehicles for pH-triggered intracellular controlled release and imaging.
    Zhou L; Li Z; Liu Z; Ren J; Qu X
    Langmuir; 2013 May; 29(21):6396-403. PubMed ID: 23642102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.